Here are relevant reports on : dementia-care-device-market
-
Asia Pacific Respiratory Care Device Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), & End User (Hospitals, ASCs) - Forecast to 2031
The Asia Pacific respiratory care devices market is projected to reach USD 8.76 billion by 2031, growing at a CAGR of 8.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030
The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of US$379.17 billion by the end of the period. The increasing prevalence of chronic diseases worldwide, coupled with the introduction and approval of innovative advanced therapeutics, is driving significant market expansion.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
US Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) - Forecast to 2031
The US injectable drug delivery market, valued at US$285.81 billion in 2025, stood at US$309.90 billion in 2026 and is projected to advance at a resilient CAGR of 8.5% from 2026 to 2031, culminating in a forecasted valuation of US$465.15 billion by the end of the period. The growth of the veterinary contract manufacturing & research market is driven by the increasing adoption of biologics and long-acting injectables, rising demand for patient-centric and self-administration delivery systems, and the need for advanced formulation, device engineering, and scalable manufacturing capabilities.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Augmented and Virtual Reality in Healthcare Market by Offering (Hardware and Software), Device Type, End User, Application (Patient Care Management, Medical Training & Education, Pharmacy Management, Surgery), and Geography - Global Forecast to 2023
The augmented and virtual reality in healthcare market was valued at USD 769.2 Million in 2017 and is expected to reach USD 4,997.9 Million by 2023, at a CAGR of 36.6% during the forecast period. Some major companies operating in the market for augmented reality in healthcare and virtual reality in healthcare are Google (US), Microsoft (US), DAQRI (US), Psious (Spain), Mindmaze (Switzerland), Firsthand Technology (US), Medical Realities (UK), Atheer (US), Augmedix (US), and Oculus VR (US). The other major players in the market include CAE Healthcare (US), Philips Healthcare (Netherlands & US), 3D Systems (US), VirtaMed (Switzerland), HTC (Taiwan), Siemens Healthineers (Germany), and Virtually Better (US).
- Published: November 2017
- Price: $ 4950
- TOC Available:
-
Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Orthopedic, Dental), Class of Device (Class I, II, III), Service (Device Development & Manufacturing, Packaging & Assembly, Quality Management) - Global Forecast to 2030
The global medical device contract manufacturing market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$140.84 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Natural Personal Care Ingredients Market by Type (Emollients, Surfactnats, Rheology Modifiers, Preservatives, Active Ingredients), Application (Skin Care, Hair Care, Make-up, Oral Care), and Region - Global Forecast to 2028
The natural personal care ingredients market is expected to grow from USD 5.3 billion in 2022 to USD 7.9 billion by 2028, at a CAGR of 8.3% during the forecast period. The key players profiled in the report include BASF SE (Germany), Croda International Plc (UK), Ashland Inc. (US), The Lubrizol Corporation (US), Evonik Industries AG (Germany), Dow Inc. (US), Symrise AG (Germany), and others.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Utility Management System Market by Smart Water Management (Device, Solution & Services), by Smart Gas Management (Device, Solution & Services), and by Smart Grid Management (Device, Solution & Services) – Global Forecast to 2019
The utilities sector is one of the top industry verticals serving large customer bases. This sector plays a vital role in the socio-economic development of any region. The government is the major stakeholder of the utilities market scenario, while very few private firms serve this market. Increased competition in the utilities sector in recent years has necessitated modifications in regulatory agendas and the proprietorship structures of the organizations involved, in addition to business divergence.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Personal Care Ingredients Market by Ingredient Type (Emollients, Surfactants, Rheology Modifiers, Emulsifiers, Conditioning Polymers), Application (Skin Care, Hair Care, Oral Care, Makeup), and Region - Global Forecast to 2030
The personal care ingredients market size was USD 13.17 billion in 2024 and is projected to reach USD 17.00 billion by 2030, at a CAGR of 4.40%, between 2025 and 2030. The key market players profiled in the report include as BASF SE (Germany), Dow Inc. (US), Syensqo SA/NV (Belgium), Clariant AG (Switzerland), Ashland Inc. (US), ADEKA Corporation (Japan), The Lubrizol Corporation (US), Evonik Industries AG (Germany), Nouryon (Netherlands), and Croda International Plc (US).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Artificial Pancreas Device System (APDS) Market by Device Type (Threshold Suspended Device System, CTT System) by Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2023
Artificial Pancreas Device Systems consists of two types of devices for diabetes monitoring: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) used to calibrate the CGM. These devices are intended to reduce hypoglycemic excursions by automatically suspending insulin administration for up to two hours when an individual’s glucose level drops below a preset level, if the individual does not respond to the threshold-suspend alarm. In 2016, the MiniMed 670G System (Medtronic), a hybrid-closed loop insulin delivery system, received FDA approval. This device is the first fully automated artificial pancreas device system. It consists of an insulin pump, a glucose meter, and a transmitter, linked by a proprietary algorithm, and the SmartGuard Hybrid Closed Loop. The system can be programmed to suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values and automatically adjust delivery of basal insulin based on continuous glucose monitor sensor glucose values.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Minimally Invasive Surgery Market by Type (Surgical Device, Imaging System, Electrosurgical Device, Endoscopy Device, Medical Robotics), Application (Urological, Vascular, Oncological), End User (Hospital, Clinic, ASC) Region-Global Forecast to 2030
The global minimally invasive surgery market, valued at US$81.65 billion in 2024, stood at US$94.45 billion in 2025 and is projected to advance at a resilient CAGR of 16.1% from 2025 to 2030, culminating in a forecasted valuation of US$199.30 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
